AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dippivi-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Jubilant Life Sciences

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Dippivi-M 50/500 Tablet

Combiflex-DM 50/500 tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications, such as renal impairment and vision loss, and may also lessen the risk of cardiovascular events. Combiflex-DM 50/500 may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, including current health status, glucose levels, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control reduces the likelihood of future complications. Maintaining the prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar regulation. Potential side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, diaphoresis, and anorexia. Hypoglycemia, especially if concurrently using insulin or sulfonylureas, is possible; patients should understand its recognition and management. This medication isn't appropriate for all patients. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before initiating therapy. Potential drug interactions exist; therefore, disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Dippivi-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Dippivi-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dippivi-M 50/500 Tablet with a meal.

Common Side effects of Dippivi-M 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Dippivi-M 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dippivi-M 50/500 Tablet with a meal.

How Dippivi-M 50/500 Tablet works:

Combinazione Diabetica DP-50/500 is a dual-action antidiabetic tablet.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Dippivi-M 50/500 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dippivi-M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Dippivi-M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Dippivi-M 50/500 Tablet requires careful administration. Dosage modification of Dippivi-M 50/500 Tablet might be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Dippivi-M 50/500 Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Dippivi-M 50/500 Tablet :

Should you forget a Dippivi-M 50/500 Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dippivi-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Dippivi-M 50/500 Tablet

Dippivi-M 50/500 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Dippivi-M 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Dippivi-M 50/500 Tablets are contraindicated in patients allergic to any ingredient. This medication should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dippivi-M 50/500 tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Dippivi-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Dippivi-M 50/500 Tablets and seek immediate medical attention.
Prolonged Dippivi-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Dippivi-M 50/500 Tablets are safe when used as directed by your doctor. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent side effects to your physician.
Dippivi-M 50/500 Tablet
105
MRP 128
17% off